Cell therapies in ovarian cancer.

Sarivalasis, Apostolos; Morotti, Matteo; Mulvey, Arthur; Imbimbo, Martina; Coukos, George

Sarivalasis, Apostolos; Morotti, Matteo; Mulvey, Arthur; Imbimbo, Martina; Coukos, George.

Afiliación

Sarivalasis A; Department of Oncology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Morotti M; Department of Oncology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Mulvey A; Department of Oncology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Imbimbo M; Department of Oncology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Coukos G; CHUV, Rue du Bugnon 46, Lausanne BH09-701, Switzerland.

Ther Adv Med Oncol ; 13: 17588359211008399, 2021.

Article en En | MEDLINE | ID: mdl-33995591

Palabras clave

adoptive cell therapy (ACT); cancer immunotherapy; neoantigens; ovarian cancer; tumor-infiltrating lymphocyte (TIL)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Ther Adv Med Oncol Año: 2021 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google